| Similar Articles |
|---|
 |
Pharmaceutical Executive
November 1, 2008
Brittany Agro |
Docs Rock the Vote Medical journal advertising takes center stage at the sixth-annual Doctor's Choice Awards.   |
Pharmaceutical Executive
March 1, 2007
George Koroneos |
Ad Stars Honoring the most innovative, creative, and thought-provoking pharmaceutical ads of 2006 - and the people who created them. |
BusinessWeek
November 4, 2009
Arlene Weintraub |
Ask Your Doctor If This Ad Is Right for You The drug industry is spending billions on TV ads, but they may be scaring consumers away |
The Motley Fool
April 10, 2007
Brian Lawler |
Barr Issues a Challenge Barr challenges the patents on one of Sanofi's top drugs. |
InternetNews
March 13, 2008 |
A New Ad Service For Google: Report Google will introduce a new service that Web publishers can use to manage their online ad sales and serve up ads each time a consumer pulls up a Web page |
The Motley Fool
January 29, 2007
Brian Lawler |
The Paris Hilton of Drug Stocks Yet another rumor about a potential merger for Bristol-Myers. Who is the winner in a Bristol-Myers and Sanofi-Aventis merger? It obviously depends on the price Sanofi is willing to pay. Investors, take note. |
The Motley Fool
October 30, 2009
Brian Orelli |
Shrugging Off the Side Effects Sanofi-aventis is looking good, but still faces the patent protection loss of Lovenox. |
The Motley Fool
September 17, 2009
Brian Orelli |
Sleepless in Sanofi It's nothing but sleepless nights for sanofi-aventis, and there's no drug to cure it. |
Pharmaceutical Executive
November 1, 2006
George Koroneos |
Global Style Of the nearly 2,000 submissions, 40 gold and silver winners stand out as benchmarks for design and originality in pharma marketing. |
BusinessWeek
June 11, 2009
Robert D. Hof |
Google's Grab for the Display Ad Market Google aims to unseat Yahoo and Microsoft with new, ultratargeted banner ads. Will Web publishers and online ad agencies bite? |
The Motley Fool
February 14, 2008
Brian Lawler |
Sanofi Stagnates French drugmaker Sanofi-Aventis posts fourth-quarter earnings in which its top drugs get some protection, but free cash flow drops. |
The Motley Fool
March 15, 2010
Brian Orelli |
Warning: Not All Boxed Warnings Are Equal Plavix's is mild in comparison. |
BusinessWeek
July 25, 2005
Jon Fine |
The "Mystical Hold" of TV Broadcast TV keeps losing audience, but the hold on its share of the ad pie still bests other big-media competitors. And there's at least one good reason why -- scarcity. |
Pharmaceutical Executive
March 1, 2011 |
Ad Stars 2011 Here, the people behind the best of pharma advertising over the past year are acknowledged. |
Pharmaceutical Executive
May 1, 2005
Kathy Kastner |
Direct to Consumer: Information vs. Education Although the pharma industry is good at providing information, it has not yet learned how to transform it into reliable education. If pharma marketers can initiate that transformation, they will grab a significant opportunity to connect with consumers. |
The Motley Fool
October 4, 2010
Brian Orelli |
That's No Way to Make Friends Sanofi goes hostile on Genzyme. |
The Motley Fool
October 31, 2007
Brian Lawler |
Sanofi: Stable, for Now The drugmaker's healthy Q3 results shine amid slumping competitors. Investors, take note. |
The Motley Fool
November 17, 2009
Dave Mock |
A Big Upgrade for Sanofi-Aventis This bullish call comes from more than just one analyst. |
Pharmaceutical Executive
February 1, 2007
Chris Saridakis |
Alternative Media: Stop, Click, and Listen Flashier rich-media advertisements add flare and functionality to otherwise static ads. |
Search Engine Watch
November 11, 2010
Mark Drummond |
The 2 Principles of Effective Performance Advertising Creating relevant ads is easy. Making people click on them? Not so much. Here's how to design a good user experience that leads to performance ads that work well. |
